Denise M. Sloan, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry

PhD, Case Western Reserve University
MA, Case Western Reserve University
BA, Stony Brook University



Denise M. Sloan, Ph.D. is a psychologist and Associate Director in the Behavioral Science Division, National Center for PTSD. She is also a Professor of Psychiatry at Chobanian and Avedisian School of Medicine.

Her research expertise is in psychosocial treatments for PTSD and emotion in psychopathology. She has received funding from her work from several organizations, including the National Institute for Mental Health and Department of Veterans Affairs. Dr. Sloan is a member of several editorial boards including Behavior Therapy, Behaviour Research and Therapy, and Journal of Abnormal Psychology.

VA Boston Healthcare System




An efficient 2-day treatment for posttraumatic injury for firefighters
09/08/2021 - 09/07/2024 (Subcontract PI)
Palo Alto Veterans Institute for Research Dept Homeland Sec


Delivering Written Exposure Therapy for PTSD in Undeserved Primary Care Settings
09/13/2021 - 06/30/2024 (Multi-PI)
PI: Denise M. Sloan, PhD
RAND Corporation NIH NIMH
1R01MH123585-01A1

Comparative effectiveness PTSD Trial of Sequenced Pharmacotherapy and Psychotherapy in Primary care
06/01/2020 - 05/31/2022 (Subcontract PI)
University of Washington Patient-Cnt.Out. Res


Written Exposure Therapy for PTSD: A Randomized Noninferiority Trial
07/01/2016 - 06/30/2019 (PI)
NIH/National Institute of Mental Health
4R01MH095737-05

Personnel Agreement for Research Services of Daniel Lee
10/01/2015 - 06/30/2016 (PI)
VA Boston Healthcare System


Personnel Agreement for Jenny Lee
11/04/2014 - 06/30/2016 (PI)
VA Boston Healthcare System


Written Exposure Therapy for PTSD: A Randomized Noninferiority Trial
09/15/2012 - 06/30/2016 (PI)
NIH/National Institute of Mental Health
5R01MH095737-04



Title
Written Exposure Treatment for PTSD: A Noninferiority Trial
(PI)

An Efficient Exposure-Based Treatment for PTSD Compared to Prolonged Exposure: A Non-Inferiority Randomized Trial
(PI)

Brief Treatment for Posttraumatic Stress Disorder: Enhancing Treatment Engagement and Retension
(PI)



Yr Title Project-Sub Proj Pubs
2024 An efficient, exposure-based treatment for PTSD compared to Prolonged Exposure: A non-inferiority randomized trial 5I01CX001967-05
2023 Delivering Written Exposure Therapy for PTSD in Underserved Primary Care Settings 5R01MH123585-03
2022 Delivering Written Exposure Therapy for PTSD in Underserved Primary Care Settings 5R01MH123585-02
2022 An efficient, exposure-based treatment for PTSD compared to Prolonged Exposure: A non-inferiority randomized trial 5I01CX001967-04
2021 Delivering Written Exposure Therapy for PTSD in Underserved Primary Care Settings 1R01MH123585-01A1
2021 An efficient, exposure-based treatment for PTSD compared to Prolonged Exposure: A non-inferiority randomized trial 5I01CX001967-03
2020 An efficient, exposure-based treatment for PTSD compared to Prolonged Exposure: A non-inferiority randomized trial 5I01CX001967-02
2019 An efficient, exposure-based treatment for PTSD compared to Prolonged Exposure: A non-inferiority randomized trial 1I01CX001967-01
2016 Written Exposure Therapy for PTSD: A Randomized Noninferiority Trial 4R01MH095737-05 10
2016 Group CBT for Chronic PTSD: RCT with Veterans 5I01CX000467-05 5
Showing 10 of 21 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Pless Kaiser A, Daks JS, Korsun L, Heintz H, Moye J, Sloan DM, Cook JM, Vogt D, Spiro A. Enhancing social functioning in older veterans with PTSD: Rationale and design of an intervention and initial RCT. Contemp Clin Trials. 2024 Apr; 139:107485.View Related Profiles. PMID: 38432471
     
  2. DeJesus CR, Trendel SL, Sloan DM. A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms. Psychol Trauma. 2024 Feb 15.View Related Profiles. PMID: 38358724
     
  3. Sloan DM. Editorial: State of the Journal. J Trauma Stress. 2024 Apr; 37(2):203-204. PMID: 38351369
     
  4. Meredith LS, Wong EC, Marx BP, Han B, Korn AR, Tobin JN, Cassells A, Williamson S, Franco M, Overa CC, Holder T, Lin TJ, Sloan DM. Design of a hybrid implementation effectiveness cluster randomized controlled trial of delivering written exposure therapy for PTSD in underserved primary care settings. Contemp Clin Trials. 2024 Mar; 138:107435.View Related Profiles. PMID: 38211725
     
  5. Lee DJ, Crowe ML, Weathers FW, Bovin MJ, Ellickson S, Sloan DM, Schnurr P, Keane TM, Marx BP. An Item Response Theory Analysis of the Clinician-Administered PTSD Scale for DSM-5 Among Veterans. Assessment. 2023 Nov 14; 10731911231202440.View Related Profiles. PMID: 37960836
     
  6. Stoycos SA, Straud CL, Stanley IH, Marx BP, Resick PA, Young-McCaughan S, Peterson AL, Sloan DM. Benchmarking secondary outcomes to posttraumatic stress disorder symptom change in response to cognitive processing and written exposure therapy for posttraumatic stress disorder. J Anxiety Disord. 2023 Dec; 100:102794.View Related Profiles. PMID: 37980801
     
  7. Shayani DR, Canale CA, Sloan DM, Hayes AM. Predictors of dropout in cognitive processing therapy for PTSD: An examination of in-session treatment processes. Behav Res Ther. 2023 Dec; 171:104428. PMID: 37952284; PMCID: PMC10826797; DOI: 10.1016/j.brat.2023.104428;
     
  8. Sloan DM, Marx BP, Acierno R, Messina M, Muzzy W, Gallagher MW, Litwack S, Sloan C. Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Nov 01; 80(11):1093-1100.View Related Profiles. PMID: 37610727; PMCID: PMC10448372; DOI: 10.1001/jamapsychiatry.2023.2810;
     
  9. Alpert E, Sloan DM, Lee DJ, Cole TA, Shotwell Tabke C. Response to Sonis's (2023) commentary on Alpert et al.'s (2023) systematic review of mediators and mechanisms of PTSD treatments. Clin Psychol Rev. 2023 Dec; 106:102338.View Related Profiles. PMID: 37858387
     
  10. Thompson-Hollands J, Lunney CA, Sloan DM, Wiltsey Stirman S, Schnurr PP. Treatment length and symptom improvement in prolonged exposure and present-centered therapy for posttraumatic stress disorder: Comparing dose-response and good-enough level models in two manualized interventions. J Consult Clin Psychol. 2023 Oct; 91(10):596-605.View Related Profiles. PMID: 37471022; PMCID: PMC10527917; DOI: 10.1037/ccp0000834;
     
Showing 10 of 136 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 136 publications over 29 distinct years, with a maximum of 12 publications in 2021

YearPublications
19951
19961
19971
19982
19992
20011
20024
20032
20043
20057
20061
20072
20085
20092
20102
20114
201210
20135
20149
20157
20169
20173
201810
20194
20205
202112
20227
202311
20244

2017 Toy Caldwell-Colbert Award for Distinguished Educator in Clinical Psychology
2015 International Society of Traumatic Stress Studies: Distinguished Mentor Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Psychosocial interventions for PTSD
Emotion Regulation and Psychopathology
Contact for Mentoring:

150 S Huntington Avenue
Jamaica Plain MA 02130
Google Map


Sloan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department